
▪ | Assets under management end quarter at $1.01 trillion |
▪ | Net client outflows of $6.0 billion for Q1 2020 |
▪ | Net revenues of $1.5 billion for Q1 2020 |
▪ | Diluted earnings per common share of $1.41 for Q1 2020 |
▪ | Adjusted non-GAAP diluted earnings per common share of $1.87 for Q1 2020 |
▪ | Repurchased 8.3 million shares at an average price of $106.43 |
▪ | Long-term investment performance remains strong |
Three Months ended | |||||||||||||||||
(in millions, except per-share data) | 3/31/2020 | 3/31/2019 | % change | 12/31/2019 | % change | ||||||||||||
U.S. GAAP basis | |||||||||||||||||
Investment advisory fees | $ | 1,327.8 | $ | 1,194.2 | 11.2 | % | $ | 1,344.7 | (1.3 | )% | |||||||
Net revenues | $ | 1,462.6 | $ | 1,327.3 | 10.2 | % | $ | 1,468.7 | (.4 | )% | |||||||
Operating expenses | $ | 755.4 | $ | 794.8 | (5.0 | )% | $ | 888.4 | (15.0 | )% | |||||||
Net operating income | $ | 707.2 | $ | 532.5 | 32.8 | % | $ | 580.3 | 21.9 | % | |||||||
Non-operating income (loss)(1) | $ | (500.3 | ) | $ | 202.8 | n/m | $ | 170.0 | n/m | ||||||||
Net income attributable to T. Rowe Price Group | $ | 343.1 | $ | 512.6 | (33.1 | )% | $ | 545.3 | (37.1 | )% | |||||||
Diluted earnings per common share | $ | 1.41 | $ | 2.09 | (32.5 | )% | $ | 2.24 | (37.1 | )% | |||||||
Weighted average common shares outstanding assuming dilution | 236.8 | 239.6 | (1.2 | )% | 237.4 | (.3 | )% | ||||||||||
Adjusted non-GAAP basis(2) | |||||||||||||||||
Operating expenses | $ | 817.9 | $ | 756.6 | 8.1 | % | $ | 863.5 | (5.3 | )% | |||||||
Net operating income | $ | 647.2 | $ | 572.2 | 13.1 | % | $ | 605.7 | 6.9 | % | |||||||
Non-operating income (loss)(1) | $ | (61.2 | ) | $ | 44.2 | n/m | $ | 27.2 | n/m | ||||||||
Net income attributable to T. Rowe Price Group | $ | 454.3 | $ | 460.6 | (1.4 | )% | $ | 495.0 | (8.2 | )% | |||||||
Diluted earnings per common share | $ | 1.87 | $ | 1.87 | — | % | $ | 2.03 | (7.9 | )% | |||||||
Assets under Management (in billions) | |||||||||||||||||
Average assets under management | $ | 1,162.7 | $ | 1,043.5 | 11.4 | % | $ | 1,162.0 | .1 | % | |||||||
Ending assets under management | $ | 1,008.8 | $ | 1,081.7 | (6.7 | )% | $ | 1,206.8 | (16.4 | )% | |||||||
Three months ended 3/31/2020 | |||||||||||||||
(in billions) | U.S. mutual funds | Subadvised and separate accounts | Other investment products | Total | |||||||||||
Assets under management at beginning of period | $ | 682.7 | $ | 313.8 | $ | 210.3 | $ | 1,206.8 | |||||||
Net cash flows before client transfers | (7.5 | ) | (3.5 | ) | 5.0 | (6.0 | ) | ||||||||
Client transfers | (4.4 | ) | — | 4.4 | — | ||||||||||
Net cash flows after client transfers | (11.9 | ) | (3.5 | ) | 9.4 | (6.0 | ) | ||||||||
Net market depreciation and losses | (108.4 | ) | (49.2 | ) | (34.3 | ) | (191.9 | ) | |||||||
Net distributions not reinvested | (.1 | ) | — | — | (.1 | ) | |||||||||
Change during the period | (120.4 | ) | (52.7 | ) | (24.9 | ) | (198.0 | ) | |||||||
Assets under management at March 31, 2020 | $ | 562.3 | $ | 261.1 | $ | 185.4 | $ | 1,008.8 | |||||||
Three months ended 3/31/2020 | |||||||||||||||
(in billions) | Equity | Fixed income, including money market | Multi-asset(1) | Total | |||||||||||
Assets under management at beginning of period | $ | 698.9 | $ | 147.9 | $ | 360.0 | $ | 1,206.8 | |||||||
Net cash flows | (5.7 | ) | 3.0 | (3.3 | ) | (6.0 | ) | ||||||||
Net market depreciation and losses(2) | (123.9 | ) | (4.6 | ) | (63.5 | ) | (192.0 | ) | |||||||
Change during the period | (129.6 | ) | (1.6 | ) | (66.8 | ) | (198.0 | ) | |||||||
Assets under management at March 31, 2020 | $ | 569.3 | $ | 146.3 | $ | 293.2 | $ | 1,008.8 | |||||||
▪ | Investment advisory revenues earned in Q1 2020 from the firm's U.S. mutual funds were $876.2 million, an increase of 7.4% from Q1 2019. Average assets under management in these funds increased 7.2% to $654.3 billion in Q1 2020. |
▪ | Investment advisory revenues earned in Q1 2020 from subadvised, separate accounts, and other investment products were $451.6 million, an increase of 19.4% from Q1 2019. Average assets under management for these products increased 17.3% to $508.4 billion in Q1 2020. |
▪ | The effective fee rate of 45.9 basis points in Q1 2020, while flat compared to Q4 2019, decreased compared to the 46.4 basis points earned in Q1 2019, primarily due to client transfers within the complex to lower fee vehicles or share classes over the last twelve months. Over time, the firm's effective fee rate can be impacted by market or cash flow related shifts among asset and share classes, price changes in existing products, and asset level changes in products with tiered-fee structures. |
▪ | Administrative, distribution, and servicing fees in Q1 2020 were $134.8 million, an increase of 1.3% from |
▪ | Compensation and related costs were $440.7 million in Q1 2020, a decrease of 10.3% compared to |
▪ | Advertising and promotion expenses were $24.9 million in Q1 2020, an increase of 15.3% over Q1 2019. The increase was primarily driven by more television media activity in Q1 2020 compared to Q1 2019. |
▪ | Technology, occupancy, and facility costs were $105.4 million in Q1 2020, an increase of 7.4% from the $98.1 million recognized in Q1 2019. The increase was due to the ongoing investment in the firm's technology capabilities, including related depreciation and hosted solution licenses. |
▪ | General, administrative, and other costs were $77.1 million in Q1 2020, an increase of 5.6% compared with the $73.0 million recognized in Q1 2019. The increase was primarily due to higher third-party investment research costs and professional fees. These higher costs were partially offset by lower travel expenses as global travel restrictions were put in place amid the coronavirus pandemic. |
Three months ended | |||||
3/31/2020 | 3/31/2019 | ||||
Statutory U.S. federal income tax rate | 21.0 | % | 21.0 | % | |
State income taxes for current year, net of federal income tax benefits(1) | 6.4 | 4.2 | |||
Net losses (income) attributable to redeemable non-controlling interests | 3.1 | (.6 | ) | ||
Net excess tax benefits from stock-based compensation plans activity | (8.1 | ) | (.6 | ) | |
Other items | (2.9 | ) | .7 | ||
Effective income tax rate | 19.5 | % | 24.7 | % | |
• | The firm's non-GAAP effective tax rate was 22.5% in Q1 2020 compared with 25.3% in Q1 2019. The non-GAAP tax rate primarily adjusts for the impact of the consolidated investment products, including the significant net losses attributable to the redeemable non-controlling interests. The decrease in the non-GAAP effective tax rate is primarily due to the higher tax benefits associated with option exercises. The firm estimates that its effective tax rate for the full-year 2020 on a non-GAAP basis will be in the range of 23.5% to 25.5%. |
(in millions) | 3/31/2020 | 12/31/2019 | ||||||
Cash and cash equivalents | $ | 1,562.4 | $ | 1,781.8 | ||||
Discretionary investments | 1,841.4 | 1,899.6 | ||||||
Total cash and discretionary investments | 3,403.8 | 3,681.4 | ||||||
Redeemable seed capital investments | 1,081.6 | 1,325.6 | ||||||
Investments used to hedge the supplemental savings plan liability | 500.0 | 561.1 | ||||||
Total cash and investments in T. Rowe Price products | $ | 4,985.4 | $ | 5,568.1 | ||||
▪ | The firm's common shares outstanding were 228.0 million at March 31, 2020, compared with 235.2 million at the end of 2019. |
▪ | In Q1 2020, the firm expended $887.0 million to repurchase 8.3 million shares, or 3.5%, of its outstanding common shares at an average price of $106.43. |
▪ | In February 2020, the firm increased its quarterly dividend by 18.4% to $.90 per common share. |
▪ | The firm invested $46.0 million during Q1 2020 in capitalized facilities and technology and expects capital expenditures, including internal labor capitalization, for 2020 to be up to $230 million, of which about three-quarters is planned for technology initiatives. These expenditures are expected to continue to be funded from the firm's operating resources. |
1 year | 3 years | 5 years | 10 years | |||||
Outperformed Morningstar median(2) | ||||||||
All funds | 50% | 60% | 72% | 76% | ||||
Multi-asset funds | 44% | 59% | 76% | 84% | ||||
Top Morningstar quartile(2) | ||||||||
All funds | 19% | 28% | 41% | 50% | ||||
Multi-asset funds | 8% | 24% | 50% | 68% | ||||
Public Relations | Investor Relations | ||
Brian Lewbart | Meghan Azevedo | ||
410-345-2242 | 410-345-2756 | ||
brian.lewbart@troweprice.com | meghan.azevedo@troweprice.com | ||
Unaudited Consolidated Statements of Income | ||||||||||||
(in millions, except per-share amounts) | ||||||||||||
Three months ended | ||||||||||||
Revenues | 3/31/2020 | 3/31/2019 | 12/31/2019 | |||||||||
Investment advisory fees | $ | 1,327.8 | $ | 1,194.2 | $ | 1,344.7 | ||||||
Administrative, distribution, and servicing fees | 134.8 | 133.1 | 124.0 | |||||||||
Net revenues | 1,462.6 | 1,327.3 | 1,468.7 | |||||||||
Operating expenses | ||||||||||||
Compensation and related costs | 440.7 | 491.5 | 528.2 | |||||||||
Distribution and servicing | 65.7 | 66.4 | 67.2 | |||||||||
Advertising and promotion | 24.9 | 21.6 | 38.3 | |||||||||
Product-related costs | 41.6 | 44.2 | 37.6 | |||||||||
Technology, occupancy, and facility costs | 105.4 | 98.1 | 117.8 | |||||||||
General, administrative, and other | 77.1 | 73.0 | 99.3 | |||||||||
Total operating expenses | 755.4 | 794.8 | 888.4 | |||||||||
Net operating income | 707.2 | 532.5 | 580.3 | |||||||||
Non-operating income (loss) | ||||||||||||
Net gains (losses) on investments | (154.6 | ) | 100.1 | 66.4 | ||||||||
Net gains (losses) on consolidated investment products | (330.3 | ) | 101.9 | 96.6 | ||||||||
Other income (loss) | (15.4 | ) | .8 | 7.0 | ||||||||
Total non-operating income (loss) | (500.3 | ) | 202.8 | 170.0 | ||||||||
Income before income taxes | 206.9 | 735.3 | 750.3 | |||||||||
Provision for income taxes | 40.3 | 181.3 | 156.4 | |||||||||
Net income | 166.6 | 554.0 | 593.9 | |||||||||
Less: net income (loss) attributable to redeemable non-controlling interests | (176.5 | ) | 41.4 | 48.6 | ||||||||
Net income attributable to T. Rowe Price Group | 343.1 | 512.6 | 545.3 | |||||||||
Less: net income allocated to outstanding restricted stock and stock unit holders | 9.4 | 13.0 | 14.6 | |||||||||
Net income allocated to T. Rowe Price Group common stockholders | $ | 333.7 | $ | 499.6 | $ | 530.7 | ||||||
Earnings per share | ||||||||||||
Basic | $ | 1.43 | $ | 2.11 | $ | 2.27 | ||||||
Diluted | $ | 1.41 | $ | 2.09 | $ | 2.24 | ||||||
Weighted-average common shares | ||||||||||||
Outstanding | 234.1 | 236.6 | 234.1 | |||||||||
Outstanding assuming dilution | 236.8 | 239.6 | 237.4 | |||||||||
Investment Advisory Revenues (in millions) | Three months ended | ||||||
3/31/2020 | 3/31/2019 | ||||||
U.S. mutual funds | |||||||
Equity and blended assets | $ | 749.8 | $ | 694.5 | |||
Fixed income, including money market | 126.4 | 121.4 | |||||
876.2 | 815.9 | ||||||
Subadvised and separate accounts and other investment products | |||||||
Equity and blended assets | 385.2 | 318.8 | |||||
Fixed income, including money market | 66.4 | 59.5 | |||||
451.6 | 378.3 | ||||||
Total | $ | 1,327.8 | $ | 1,194.2 | |||
Assets Under Management (in billions) | Average during | |||||||||||||||
Three months ended | As of | |||||||||||||||
3/31/2020 | 3/31/2019 | 3/31/2020 | 12/31/2019 | |||||||||||||
U.S. mutual funds | ||||||||||||||||
Equity and blended assets | $ | 525.0 | $ | 487.6 | $ | 443.6 | $ | 552.4 | ||||||||
Fixed income, including money market | 129.3 | 122.5 | 118.7 | 130.3 | ||||||||||||
654.3 | 610.1 | 562.3 | 682.7 | |||||||||||||
Subadvised and separate accounts and other investment products | ||||||||||||||||
Equity and blended assets | 396.3 | 332.9 | 340.9 | 412.1 | ||||||||||||
Fixed income, including money market | 112.1 | 100.5 | 105.6 | 112.0 | ||||||||||||
508.4 | 433.4 | 446.5 | 524.1 | |||||||||||||
Total | $ | 1,162.7 | $ | 1,043.5 | $ | 1,008.8 | $ | 1,206.8 | ||||||||
Net Cash Flows After Client Transfers (by investment vehicle and underlying asset class)(1)(2) | Three months ended | |||
(in billions) | 3/31/2020 | |||
U.S. mutual funds | ||||
Equity and blended assets | $ | (4.3 | ) | |
Fixed income, including money market | (7.6 | ) | ||
(11.9 | ) | |||
Subadvised and separate accounts and other investment products | ||||
Equity and blended assets | 9.8 | |||
Fixed income, including money market | (3.9 | ) | ||
5.9 | ||||
Total net cash flows after client transfers | $ | (6.0 | ) | |
Non-Operating Income (Loss) (in millions) | Three months ended | ||||||
3/31/2020 | 3/31/2019 | ||||||
Net gains (losses) from non-consolidated T. Rowe Price investment products | |||||||
Cash and discretionary investments | |||||||
Dividend income | $ | 10.4 | $ | 16.2 | |||
Market related gains (losses) and equity in earnings | (71.6 | ) | 28.0 | ||||
Seed capital investments | |||||||
Dividend income | .7 | .5 | |||||
Market related gains (losses) and equity in earnings | (34.1 | ) | 19.6 | ||||
Net gain recognized upon deconsolidation | .1 | .1 | |||||
Investments used to hedge the supplemental savings plan liability | (68.5 | ) | 31.0 | ||||
Total net gains (losses) from non-consolidated T. Rowe Price investment products | (163.0 | ) | 95.4 | ||||
Other investment income | 8.4 | 4.7 | |||||
Net gains (losses) on investments | (154.6 | ) | 100.1 | ||||
Net gains (losses) on consolidated sponsored investment portfolios | (330.3 | ) | 101.9 | ||||
Other income (loss), including foreign currency gains and losses | (15.4 | ) | .8 | ||||
Non-operating income (loss) | $ | (500.3 | ) | $ | 202.8 | ||
Unaudited Condensed Consolidated Cash Flows Information (in millions) | ||||||||||||||||||||||||
Three months ended | ||||||||||||||||||||||||
3/31/2020 | 3/31/2019 | |||||||||||||||||||||||
Cash flow attributable to T. Rowe Price Group | Cash flow attributable to consolidated T. Rowe Price investment products, net of eliminations | As reported on statement of cash flows | Cash flow attributable to T. Rowe Price Group | Cash flow attributable to consolidated T. Rowe Price investment products, net of eliminations | As reported on statement of cash flows | |||||||||||||||||||
Cash provided by (used in) operating activities, including $58.3 of stock-based compensation expense and $46.1 of depreciation expense in 2020 | $ | 864.0 | $ | (76.3 | ) | $ | 787.7 | $ | 673.4 | $ | (94.7 | ) | $ | 578.7 | ||||||||||
Cash provided by (used in) investing activities, including $(46.0) for additions to property and equipment, $(225.1) of additions and $299.1M of dispositions to T. Rowe Price investment products in 2020 | (15.0 | ) | 42.6 | 27.6 | (69.2 | ) | 35.4 | (33.8 | ) | |||||||||||||||
Cash provided by (used in) financing activities, including T. Rowe Price Group common stock repurchases of $(891.3)* and dividends paid of $(215.2) in 2020 | (1,068.4 | ) | 76.1 | (992.3 | ) | (372.0 | ) | 66.0 | (306.0 | ) | ||||||||||||||
Effect of exchange rate changes on cash and cash equivalents | — | (1.2 | ) | (1.2 | ) | — | (.7 | ) | (.7 | ) | ||||||||||||||
Net change in cash and cash equivalents during period | $ | (219.4 | ) | $ | 41.2 | $ | (178.2 | ) | $ | 232.2 | $ | 6.0 | $ | 238.2 | ||||||||||
Unaudited Condensed Consolidated Balance Sheet Information (in millions) | As of | |||||||
3/31/2020 | 12/31/2019 | |||||||
Cash and cash equivalents | $ | 1,562.4 | $ | 1,781.8 | ||||
Accounts receivable and accrued revenue | 585.3 | 646.6 | ||||||
Investments | 2,731.3 | 2,939.8 | ||||||
Assets of consolidated T. Rowe Price investment products | 2,024.3 | 2,276.9 | ||||||
Operating lease assets | 137.6 | 110.8 | ||||||
Property and equipment, net | 675.2 | 674.4 | ||||||
Goodwill | 665.7 | 665.7 | ||||||
Other assets | 255.1 | 234.4 | ||||||
Total assets | 8,636.9 | 9,330.4 | ||||||
Supplemental savings plan liability | 504.2 | 563.4 | ||||||
Total other liabilities, includes $82.9 at March 31, 2020, and $39.2 at December 31, 2019, from consolidated T. Rowe Price investment products | 727.7 | 543.9 | ||||||
Redeemable non-controlling interests | 971.0 | 1,121.0 | ||||||
Stockholders' equity, 228.0 common shares outstanding at March 31, 2020 | $ | 6,434.0 | $ | 7,102.1 | ||||
Cash, Cash Equivalents, and Investments Information (in millions) | ||||||||||||||||
Cash and cash equivalents | Investments | Net assets of consolidated T. Rowe Price investment products* | 3/31/2020 | |||||||||||||
Cash and discretionary investments | $ | 1,562.4 | $ | 1,727.2 | $ | 114.2 | $ | 3,403.8 | ||||||||
Seed capital investments | — | 225.4 | 856.2 | 1,081.6 | ||||||||||||
Investments used to hedge the supplemental savings plan liability | — | 500.0 | — | 500.0 | ||||||||||||
Total cash and investments in T. Rowe Price products attributable to T. Rowe Price Group | 1,562.4 | 2,452.6 | 970.4 | 4,985.4 | ||||||||||||
Investment in UTI and other investments | — | 278.7 | — | 278.7 | ||||||||||||
Total cash and investments attributable to T. Rowe Price Group | 1,562.4 | 2,731.3 | 970.4 | 5,264.1 | ||||||||||||
Redeemable non-controlling interests | — | — | 971.0 | 971.0 | ||||||||||||
As reported on unaudited condensed consolidated balance sheet at March 31, 2020 | $ | 1,562.4 | $ | 2,731.3 | $ | 1,941.4 | $ | 6,235.1 | ||||||||
Three months ended 3/31/2020 | |||||||||||||||||||||||
Operating expenses | Net operating income | Non-operating income (loss) | Provision (benefit) for income taxes(4) | Net income attributable to T. Rowe Price Group | Diluted earnings per share(5) | ||||||||||||||||||
U.S. GAAP Basis | $ | 755.4 | $ | 707.2 | $ | (500.3 | ) | $ | 40.3 | $ | 343.1 | $ | 1.41 | ||||||||||
Non-GAAP adjustments: | |||||||||||||||||||||||
Consolidated T. Rowe Price investment products(1) | (1.2 | ) | 3.7 | 330.3 | 71.1 | 86.4 | .36 | ||||||||||||||||
Supplemental savings plan liability(2) | 63.7 | (63.7 | ) | 68.5 | 2.1 | 2.7 | .01 | ||||||||||||||||
Other non-operating income(3) | — | — | 40.3 | 18.2 | 22.1 | .09 | |||||||||||||||||
Adjusted Non-GAAP Basis | $ | 817.9 | $ | 647.2 | $ | (61.2 | ) | $ | 131.7 | $ | 454.3 | $ | 1.87 | ||||||||||
Three months ended 3/31/2019 | |||||||||||||||||||||||
Operating expenses | Net operating income | Non-operating income (loss) | Provision (benefit) for income taxes(4) | Net income attributable to T. Rowe Price Group | Diluted earnings per share(5) | ||||||||||||||||||
U.S. GAAP Basis | $ | 794.8 | $ | 532.5 | $ | 202.8 | $ | 181.3 | $ | 512.6 | $ | 2.09 | |||||||||||
Non-GAAP adjustments: | |||||||||||||||||||||||
Consolidated T. Rowe Price investment products(1) | (1.6 | ) | 3.1 | (101.9 | ) | (18.9 | ) | (38.5 | ) | (.16 | ) | ||||||||||||
Supplemental savings plan liability(2) | (36.6 | ) | 36.6 | (31.0 | ) | 1.8 | 3.8 | .01 | |||||||||||||||
Other non-operating income(3) | — | — | (25.7 | ) | (8.4 | ) | (17.3 | ) | (.07 | ) | |||||||||||||
Adjusted Non-GAAP Basis | $ | 756.6 | $ | 572.2 | $ | 44.2 | $ | 155.8 | $ | 460.6 | $ | 1.87 | |||||||||||
Three months ended 12/31/2019 | |||||||||||||||||||||||
Operating expenses | Net operating income | Non-operating income (loss) | Provision (benefit) for income taxes(4) | Net income attributable to T. Rowe Price Group | Diluted earnings per share(5) | ||||||||||||||||||
U.S. GAAP Basis | $ | 888.4 | $ | 580.3 | $ | 170.0 | $ | 156.4 | $ | 545.3 | $ | 2.24 | |||||||||||
Non-GAAP adjustments: | |||||||||||||||||||||||
Consolidated T. Rowe Price investment products(1) | (3.6 | ) | 4.1 | (96.6 | ) | (12.0 | ) | (31.9 | ) | (.13 | ) | ||||||||||||
Supplemental savings plan liability(2) | (21.3 | ) | 21.3 | (23.1 | ) | (.4 | ) | (1.4 | ) | (.01 | ) | ||||||||||||
Other non-operating income(3) | — | — | (23.1 | ) | (6.3 | ) | (16.8 | ) | (.07 | ) | |||||||||||||
Adjusted Non-GAAP Basis | $ | 863.5 | $ | 605.7 | $ | 27.2 | $ | 137.7 | $ | 495.2 | $ | 2.03 | |||||||||||
(1) | These non-GAAP adjustments remove the impact the consolidated T. Rowe Price investment products have on the firm's U.S. GAAP consolidated statements of income. Specifically, the firm adds back the operating expenses and subtracts the investment income of the consolidated T. Rowe Price investment products. The adjustment to operating expenses represents the operating expenses of the consolidated products, net of the elimination of related management and administrative fees. The adjustment to net income attributable to T. Rowe Price Group represents the net income of the consolidated products, net of redeemable non-controlling interests. Management believes the consolidated T. Rowe Price investment products may impact the reader’s ability to understand the firm's core operating results. |
(2) | This non-GAAP adjustment removes the compensation expense impact from market valuation changes in the supplemental savings plan liability and the related net gains (losses) on investments designated as an economic hedge against the related liability. Amounts deferred under the supplemental savings plan are adjusted for appreciation (depreciation) of hypothetical investments chosen by participants. The firm uses T. Rowe Price investment products to economically hedge the exposure to these market movements. Management believes it is useful to offset the non-operating investment income (loss) realized on the hedges against the related compensation expense and remove the net impact to help the reader's ability to understand the firm's core operating results and to increase comparability period to period. |
(3) | This non-GAAP adjustment represents the other non-operating income (loss) and the net gains (losses) earned on the firm's non-consolidated investment portfolio that are not designated as economic hedges of the supplemental savings plan liability, and those non-consolidated investments that are not part of the cash and discretionary investment portfolio. Management retains the investment gains recognized on the non-consolidated cash and discretionary investments as these assets and related income (loss) are considered part of the firm's core operations. Management believes adjusting for these non-operating income (loss) items helps the reader’s ability to understand the firm's core operating results and increases comparability to prior years. Additionally, management does not emphasize the impact of the portion of non-operating income (loss) removed when managing and evaluating the firm's performance. |
(4) | The income tax impacts were calculated in order to achieve an overall year-to-date non-GAAP effective tax rate of 22.5% for 2020, 25.3% for Q1 2019, and 21.8% for Q4 2019. The firm estimates that its effective tax rate for the full-year 2020 on a non-GAAP basis will be in the range of 23.5% to 25.5%. |
(5) | This non-GAAP measure was calculated by applying the two-class method to adjusted net income attributable to T. Rowe Price Group divided by the weighted-average common shares outstanding assuming dilution. The calculation of adjusted net income allocated to common stockholders is as follows: |
Three months ended | ||||||||||
3/31/2020 | 3/31/2019 | 12/31/2019 | ||||||||
Adjusted net income attributable to T. Rowe Price Group | $ | 454.3 | $ | 460.6 | $ | 495.2 | ||||
Less: adjusted net income allocated to outstanding restricted stock and stock unit holders | 12.4 | 11.6 | 13.3 | |||||||
Adjusted net income allocated to common stockholders | $ | 441.9 | $ | 449.0 | $ | 481.9 | ||||